Alter Pharma Group CEO Filip Van de Vliet and Gérard Lefèbvre, Head of BU Pharmacy Sales, gave an interview to Pharma Boardroom. In the interview that appeared on 20 May 2020, they shared their insights on the value that parallel importing is bringing to Belgian patients and the evolving relationship between parallel importers and the wider pharma industry, as well as on Alter Pharma’s planned launch of generic medicines in the US market and the Group’s strategy for success.

Read the interview, which will also appear in the Belgium 2020 Edition of Healthcare & Life Sciences Reviewhere or on the Pharma Boardroom website.

Pharma Boardroom is the premier website for C-Level executives, consultants, regulators and vendors working in Healthcare & the Life Sciences globally.